Finance

Lists
CRBU:NASDAQ
Caribou Biosciences Inc
0,46 $
+1,02%
(+0,0047) 1D
15 հոկ, 09:36:34 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBU...
Open
0,46 $
High
0,46 $
Low
0,46 $
Mkt. cap
49,83 մլն
Avg. vol.
3,77 մլն
Volume
8,60 հզր
52-wk high
3,54 $
52-wk low
0,44 $
EPS
-1,08 $
Beta
2,31
Shares outstanding
107,21 մլն
No. of employees
97
Open
0,46 $
High
0,46 $
Low
0,46 $
Mkt. cap
49,83 մլն
Avg. vol.
3,77 մլն
Volume
8,60 հզր
52-wk high
3,54 $
52-wk low
0,44 $
EPS
-1,08 $
Beta
2,31
Shares outstanding
107,21 մլն
No. of employees
97
News stories
From web sources and news partners
About Caribou Biosciences Inc
CEO-
Employees97
Founded01 հնվ, 2011 թ.
HeadquartersԲերքլի, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitecariboubio.com
Analyst ratings
Based on 6 analysts giving stock ratings to CRBU in the past 3 months
Buy
Buy
2
Hold
4
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for CRBU in the last 3 months.
Highest
Current 0,46 $
8,00 $ (+1 621,17%)
Average
3,75 $ (+706,80%)
Lowest
1,00 $ (+115,15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Hold
Downgraded
-
-
10/08/2026
Daina Graybosch
Leerink Partners
Hold
Downgraded
1,00 $
+115,1%
10/07/2026
Luca Issi
RBC Capital
Hold
Downgraded
1,00 $
+115,1%
10/06/2026
Leah R. Cann
Brookline Capital Markets
Hold
Downgraded
-
-
10/06/2026
Alec Stranahan
Bank of America Securities
Buy
Maintained
5,00 $
+975,7%
08/14/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
8,00 $
+1 621,2%
08/13/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
13,00 $
+2 696,9%
03/09/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
7,00 $
+1 406%
03/09/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
4,00 $
+760,6%
03/06/2026
William Maughan
Clear Street
Buy
Maintained
13,00 $
+2 696,9%
03/06/2026
Last report
13 օգս, 2026 թ.
Fiscal period
Q2 2026
-0,24 $ / -0,31 $
+21,74%beat
Revenue / Est. (USD)
1,50 մլն / 2,25 մլն
-33,25%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
2,20 մլն
3,94 մլն
2,40 մլն
1,50 մլն
Cost of goods sold
22,40 մլն
23,82 մլն
20,61 մլն
18,94 մլն
Cost of revenue
22,40 մլն
23,82 մլն
20,61 մլն
18,94 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,20 մլն
8,58 մլն
8,07 մլն
7,90 մլն
Operating expense
9,20 մլն
8,58 մլն
8,07 մլն
7,90 մլն
Total operating expenses
31,60 մլն
32,39 մլն
28,68 մլն
26,84 մլն
Operating income
-29,40 մլն
-28,45 մլն
-26,28 մլն
-25,34 մլն
Other non operating income
-
42,00 հզր
-
-
EBT including unusual items
-27,55 մլն
-27,04 մլն
-25,08 մլն
-24,28 մլն
EBT excluding unusual items
-27,55 մլն
-27,04 մլն
-25,08 մլն
-24,28 մլն
Income tax expense
-
-550,00 հզր
-
-
Effective tax rate
-
2,03%
-
-
Other operating expenses
-
-
-
-
Net income
-27,55 մլն
-26,49 մլն
-25,08 մլն
-24,28 մլն
Net profit margin
-1 253,32%
-672,11%
-1 046,52%
-1 619,88%
Earnings per share
-
-
-0,26
-0,24
Interest and investment income
1,85 մլն
1,37 մլն
1,20 մլն
1,06 մլն
Interest expense
-
-
-
-
Net interest expenses
1,85 մլն
1,37 մլն
1,20 մլն
1,06 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-28,77 մլն
-27,77 մլն
-25,63 մլն
-24,71 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps